FIELD: medicine, pharmacology, immunology.
SUBSTANCE: invention relates an agent comprising essential phospholipids and proposes to use its for the following aims: for retention and recovery structure and function of thymus, lymphatic nodes, spleen and for retention lymphoepithelial parenchyma in cortex and medullar substance in them; thymocytes and lymphatic node and spleen cells; ultrastructure of mitochondria and granular endoplasmatic reticulum; ultrastructure of reticular epithelial cells and lymphoblasts, T-lymphocytes and macrophages; ultrastructure of hematothymic barrier in thymus; for delaying transformation of cells of thymus, spleen and lymphatic nodes to fibroblast-like cells; for activation neoangiogenesis in lymphoid organs; optimization of transendothelial exchange in them; enhancing micropinocytosis activity of endotheliocytes, elevating formation of microvilli and growths on luminal surfaces of endotheliocytes; for improvement of protein-synthetic function of cells of these organs, elevating amount of ribosomes in them; optimization of energy-producing function of cells of these organs; for enhancing content of functionally active lymphoid tissue in them, enhancing proliferation of lymphoepithelial tissue and reducing apoptosis rate; enhancing process of cellular restoration; optimization of secretory activity of subcellular structures, process of secret extrusion; for reducing degree of infiltration of thymus, spleen and lymphatic nodes by plasmatic and eosinophilic granulocytes, mast cells; for retention and recovery structural-functional parameters of endotheliocytes of circulatory capillaries in thymus, spleen and lymphoid nodes; reducing degree of perivascular and stromal fibrosis in thymus, spleen and lymphatic nodes, diminishing amount of reticular cells in them and microfilaments in endotheliocytes; reducing degenerative-dystrophic changes in thymus, spleen and lymphatic nodes; delaying involutional rearrangement of lymphoid organs; normalization of immunostructural homeostasis; enhancing immune response for T-dependent antigen; activation of T-cellular link of immunity. Invention provides protection of lymphoid organs against vibrating damage effect.
EFFECT: valuable medicinal properties of agent.
23 cl, 34 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION SORPTION METHOD FOR TREATING ACUTE NONSPECIFIC METROENDOMETRITIS | 1995 |
|
RU2121842C1 |
AGENT LIMITING LYMPHOTOXIN EFFECT OF METHOTREXATE | 2007 |
|
RU2337693C1 |
METHOD FOR IMMUNOPROPHYLAXIS IN ANIMALS | 2022 |
|
RU2808574C1 |
AGENT IMPROVING HEMO- AND LYMPHOCIRCULATION AND ENHANCING REGENERATIVE PROCESSES IN LYMPH NODES AT ARTERIAL ISCHEMIA | 1992 |
|
RU2094049C1 |
METHOD FOR PREVENTING FUNCTIONAL DYSPEPSIA AND PHYSIOLOGICAL IMUNODEFICIENCY IN CALVES | 2004 |
|
RU2269351C1 |
MATERIALS AND METHOD FOR MODULATION OF PROLIFERATION AND DIFFERENTIATION OF REGULATORY, STEM AND OTHER SOMATIC CELLS | 2014 |
|
RU2620069C2 |
METHOD FOR OPTIMIZING FUNCTIONS OF LYMPH NODES BY METHOD OF CLOSED NON-INVASIVE LAVAGE OF LYMPHATIC SYSTEM | 2021 |
|
RU2777208C1 |
THYMUS DEFICIENCY SIMULATING METHOD | 0 |
|
SU1040510A1 |
METHOD FOR STIMULATING IMMUNE RESPONSE IN EXPERIMENT | 2003 |
|
RU2254141C1 |
PEPTIDE POSSESSING IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301074C1 |
Authors
Dates
2004-08-10—Published
2002-07-17—Filed